Pacira BioSciences (PCRX) Non Operating Income: 2010-2025
Historic Non Operating Income for Pacira BioSciences (PCRX) over the last 16 years, with Sep 2025 value amounting to $3.2 million.
- Pacira BioSciences' Non Operating Income rose 371.24% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.7 million, marking a year-over-year decrease of 129.84%. This contributed to the annual value of -$373,000 for FY2024, which is 100.54% down from last year.
- Pacira BioSciences' Non Operating Income amounted to $3.2 million in Q3 2025, which was up 129.44% from -$10.7 million recorded in Q2 2025.
- Pacira BioSciences' Non Operating Income's 5-year high stood at $27.3 million during Q4 2022, with a 5-year trough of -$23.4 million in Q1 2023.
- Over the past 3 years, Pacira BioSciences' median Non Operating Income value was $428,000 (recorded in 2024), while the average stood at -$129,091.
- Its Non Operating Income has fluctuated over the past 5 years, first plummeted by 331.67% in 2021, then surged by 1,469.16% in 2025.
- Quarterly analysis of 5 years shows Pacira BioSciences' Non Operating Income stood at -$10.4 million in 2021, then spiked by 361.88% to $27.3 million in 2022, then dropped by 3.37% to $26.3 million in 2023, then plummeted by 137.27% to -$9.8 million in 2024, then soared by 371.24% to $3.2 million in 2025.
- Its Non Operating Income stands at $3.2 million for Q3 2025, versus -$10.7 million for Q2 2025 and $6.7 million for Q1 2025.